dasatinib/teva f.c.tab 20mg/tab
teva b.v., the netherlands swensweg 5, 2031 ga haarlem +310 20 2193200 - dasatinib monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 20mg/tab - dasatinib monohydrate 20,739mg - dasatinib
dasatinib/teva f.c.tab 100mg/tab
teva b.v., the netherlands swensweg 5, 2031 ga haarlem +310 20 2193200 - dasatinib monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 100mg/tab - dasatinib monohydrate 103,693mg - dasatinib
dasatinib/teva f.c.tab 70mg/tab
teva b.v., the netherlands swensweg 5, 2031 ga haarlem +310 20 2193200 - dasatinib monohydrate - f.c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΜΕ ΛΕΠΤΟ ΥΜΕΝΙΟ ΔΙΣΚΙΟ) - 70mg/tab - dasatinib monohydrate 72,585mg - dasatinib
rasagiline actavis 1mg/tab δισκιο
actavis group ptc ehf., iceland - rasagiline tartrate - ΔΙΣΚΙΟ - 1mg/tab - 0136236527 - rasagiline tartrate - 1.440000 mg - rasagiline
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Αντινεοπλασματικοί παράγοντες - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - Αντινεοπλασματικοί παράγοντες - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib/teva 50mg film coated tablets
teva bv (0000009526) swensweg 5, haarlem, 2031 ga - dasatinib monohydrate - film coated tablets - 50mg - dasatinib monohydrate (863127779) 51,847mg
dasatinib/teva 70mg film coated tablets
teva bv (0000009526) swensweg 5, haarlem, 2031 ga - dasatinib monohydrate - film coated tablets - 70mg - dasatinib monohydrate (863127779) 72,585mg
dasatinib/teva 20mg film coated tablets
teva bv (0000009526) swensweg 5, haarlem, 2031 ga - dasatinib monohydrate - film coated tablets - 20mg - dasatinib monohydrate (863127779) 20,739mg
dasatinib/teva 100mg film coated tablets
teva bv (0000009526) swensweg 5, haarlem, 2031 ga - dasatinib monohydrate - film coated tablets - 100mg - dasatinib monohydrate (863127779) 103,693mg